Evidence map›Paper›PMID 24692191›Full record

ReviewCold Spring Harbor perspectives in medicine2014

Gene therapy for skin diseases.

Emily Gorell, Ngon Nguyen, Alfred Lane, Zurab Siprashvili

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Review
  3. Cell Therapy and the Skin: Great Potential but in Need of Optimization.The Journal of investigative dermatology · 2025
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Pathogenetic Therapy of Epidermolysis Bullosa: Current State and Prospects.Bulletin of experimental biology and medicine · 2021
    Review
  13. Review
  14. [Ex vivo stem cell gene therapy of the skin : Ready for clinical use?]Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2020
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Gene Therapy for Epidermolysis Bullosa: Sticky Business.Molecular therapy : the journal of the American Society of Gene Therapy · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Emily GorellDepartment of Dermatology, Stanford School of Medicine, Palo Alto, California 94305.
Ngon Nguyen
Alfred Lane
Zurab Siprashvili
Stanford Medicine · US

Funding

Gene Transfer for Recessive Dystrophic Epidermolysis BullosaR01AR055914 · NIAMS · STANFORD UNIVERSITY · PI KHAVARI, PAUL, LANE, ALFRED T · 2009 to 2015
$3.5M
NIAMS NIH HHS R01 AR055914
6 · The paper itself

Abstract

The skin possesses qualities that make it desirable for gene therapy, and studies have focused on gene therapy for multiple cutaneous diseases. Gene therapy uses a vector to introduce genetic material into cells to alter gene expression, negating a pathological process. This can be accomplished with a variety of viral vectors or nonviral administrations. Although results are promising, there are several potential pitfalls that must be addressed to improve the safety profile to make gene therapy widely available clinically.

Indexed as

Genetic TherapyGene Transfer TechniquesHumansSkin DiseasesTreatment OutcomeWound Healing

Identifiers

PMID24692191
PMCPMC3968787
OpenAlexW2153564232

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.